Clinical Trial Update: Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials

View source ↗

Summary

Long-term follow-up update on AvenCell-sponsored CAR-T cell trials for B-cell lymphoma and chronic lymphocytic leukemia with ongoing enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Chronic Lymphocytic Leukemia

Drugs mentioned

• AvenCell CAR-T (Chimeric antigen receptor T cell therapy targeting CD19)

Snippet

Sponsor: AvenCell Therapeutics, Inc. | Conditions: B-cell Lymphoma, Chronic Lymphocytic Leukemia | Status: ENROLLING_BY_INVITATION